AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its fourth quarter and full year 2016 financial results on Wednesday, March 8, 2017 after the market close.
Apollo will hold a conference call on Wednesday, March 8, 2017 at 3:30 p.m. CT / 4:30 p.m. ET to discuss the results. The dial-in numbers are (888) 208-1814 for domestic callers and (719) 234-0008 for international callers. The conference ID number is 1867038.
A telephonic replay of the call will be available until March 15, 2017. The replay dial-in numbers are (844)-512-2921 for domestic callers and (412) 317-6671 for international callers. Please use the replay conference ID number 1867038.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today.
Apollo’s common stock is traded on NASDAQ Global Market under the symbol "APEN." For more information regarding Apollo Endosurgery, go to: www.apolloendo.com
